by admin | Apr 16, 2021 | News
Labiotech.eu just published an article featuring the interview with Exogenus’ CEO and CSO, Joana Correia, discussing the disparity in funding opportunities seen in Europe vs USA. The article, which also quotes Antonin de Fougerolles (Evox Therapeutics, CEO) and...
by admin | Mar 1, 2021 | News
Exosome RNA, an online publication featuring the hottest trends in global exosome research, recently highlighted Exogenus Therapeutics’ contribution to the field, by mentioning our recent publication in Stem Cells Translational Medicine. Exogenus Therapeutics...
by admin | Feb 25, 2021 | News
Labiotech.eu, a biotechnology-centered online issue, published an article about exosomes, featuring Exogenus Therapeutics as one of the leading exosome biotechnology companies in Europe. The piece delves into the most recent advances in exosome-based therapeutics and...
by admin | Feb 12, 2021 | News
A paper entitled “Development of an optimized and scalable method for isolation of umbilical cord blood‐derived small extracellular vesicles for future clinical use” was just published in STEM CELLS Translational Medicine. The publication details the protocol...
by admin | Dec 22, 2020 | News
Exogenus Therapeutics is currently developing an innovative treatment for acute lung inflammation, based on naturally-occurring vesicles that facilitate cellular communication. After securing funding from Portugal 2020 and the European Union for its ExoLUNG project,...
by admin | Nov 23, 2020 | News
Joana Correia, CEO and CSO of Exogenus Therapeutics is an invited speaker at the 2nd Exosome Based Therapeutic Development Summit, taking place during November 11-12 (online). Joana will be joined by other world leaders in exosome development to discuss the pains and...
